Han River Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Earliearli.comin𝕏Jan 2021
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Co-founder)inDr. David Suhy(Co-founder & Chief Scientific Officer)
BoardJustin Kao(Director)inJorge Conde(Director)in
Co-investorsAndreessen HorowitzBreyer CapitalMenlo VenturesDFJMBX Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.